
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. (OLMA)
WebsitePrice
Market cap
Next catalystDec 9, 2026OP-3136 — breast cancer monotherapy and endocrine combinations · Phase 1/2 dataCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved